BioAtla News

BTIG Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $13

Futu NewsSep 24 19:33

Buy Rating Affirmed for BioAtla Amidst Strategic Collaborations and Promising Clinical Catalysts

TipRanksSep 24 19:00

BioAtla Analyst Ratings

BenzingaSep 16 21:55

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $5 Price Target

BenzingaSep 16 21:55

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Futu NewsSep 16 12:31

BTIG Initiates BioAtla(BCAB.US) With Buy Rating, Announces Target Price $13

Futu NewsAug 20 20:31

Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook

TipRanksAug 20 19:39

Reni Benjamin's Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside Potential

TipRanksAug 13 12:32

BioAtla (BCAB) Receives a Buy From J.P. Morgan

TipRanksJul 29 12:57

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Futu NewsJul 26 13:32

Buy Rating for BioAtla: Promising Clinical Assets and Undervaluation Present Investment Opportunity

TipRanksJul 26 12:49

Buy Rating Affirmed for BioAtla on Strong Clinical Data and Robust Financials

TipRanksJun 3 12:48

BioAtla Analyst Ratings

BenzingaMay 24 00:10

JMP Securities Maintains Market Outperform on BioAtla, Lowers Price Target to $5

BenzingaMay 24 00:10

Buy Rating for BioAtla: Promising Clinical Data and Strong Financial Position Signal Upside Potential

TipRanksMay 23 12:40

HC Wainwright & Co. : The BioAtla (BCAB.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.

Zhitong FinanceMay 15 23:20

BioAtla Analyst Ratings

BenzingaMay 15 23:20

HC Wainwright & Co. Reiterates Buy on BioAtla, Maintains $7 Price Target

BenzingaMay 15 23:20

Buy Rating Affirmed for BioAtla on Strong Clinical Data and Strategic Pipeline Progress

TipRanksMay 15 18:31

Buy Rating Affirmed for BioAtla on Strong Clinical Pipeline and Financial Stability

TipRanksApr 11 07:12